Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Artemether-Lumefantrine by Community Health Workers for Malaria in Children
NCT00454961Phase 4Completed
- Sponsor
- Karolinska University Hospital
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Plasmodium falciparum malaria, sponsored by Karolinska University Hospital. Primary endpoint: Effectiveness (PCR adjusted parasitological cure rate) of artemether-lumefantrine at 42 days. Started Apr 2007; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00454961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454961.